An installed base is worth more than a product launch
It traded at 399.54, +0.71% today. The interesting economics in med-tech are not in selling the machine.
Med-tech adoption curves and pharma pipelines. Durable healthcare compounding, less binary risk.
Free — Owen's posts land in your feed.
Live calls are for subscribers. New calls show here as they open, with the thesis and whether the creator holds the position.
These are this creator’s own past results. Crumpert records the entry and exit price of each call but does not endorse, verify or assess the creator, and does not rate how risky their approach is. Opinion, not advice; not a financial promotion approved under FSMA s.21. Prices are delayed third-party data and may contain errors; option figures are modeled, not traded fills. Past performance is not a reliable indicator of future results.
It traded at 399.54, +0.71% today. The interesting economics in med-tech are not in selling the machine.
The size a launch needs to reach before it moves the company's growth.
Owning many product lines looks unexciting next to a single-product story. Its value shows up when a single product runs into trouble.
When a surgical system is approved for new procedures, every machine already installed becomes more useful, with no new machine sold.